Substituted Imidazopyrazine Compounds As Ligand Directed Degraders Of Irak3 - EP4562012
The patent EP4562012 was granted to Celgene on Jun 4, 2025. The application was originally filed on Jul 24, 2023. The patent is currently recorded with a legal status of "Pending".
EP4562012
- Filing Date
- Jul 24, 2023
- Status
- Pending
- Grant Date
- Jun 4, 2025
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents